Idexx Laboratories (IDXX)
434.00 x 1 467.00 x 2
Pre-market by (Cboe BZX)
436.97 +2.98 (+0.69%) 04/29/25 [NASDAQ]
434.00 x 1 467.00 x 2
Pre-market 436.60 -0.37 (-0.08%) 08:02 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | IDXX | EW | DXCM | ||
| Company | Idexx Laboratories | Edwards Lifesciences Corp | Dexcom Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 433.69 | 75.50 | 71.28 | ||
| High | 439.01 | 76.58 | 71.46 | ||
| Low | 429.11 | 74.96 | 70.29 | ||
| Last | 436.97 | 76.28 | 71.30 | ||
| Change | +2.98 | +0.74 | +0.12 | ||
| % Change | +0.69% | +0.98% | +0.17% | ||
| Volume | 718,400 | 4,491,100 | 2,332,000 | ||
| 20-Day Average Volume | 1,085,465 | 5,376,675 | 4,646,265 | ||
| Previous Close | 433.99 | 75.54 | 71.18 | ||
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 409.30 | 71.32 | 66.89 | ||
| 20-Day Raw Stochastic | 94.28% | 97.00% | 86.23% | ||
| 20-Day Relative Strength | 55.91% | 61.31% | 50.41% | ||
| Weighted Alpha | -8.21 | +4.17 | -20.52 | ||
| Today's Opinion | 24% Sell | 64% Buy | 72% Sell | ||
| Previous Opinion | 40% Sell | 56% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Sell | 40% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.65% since 04/22/25 | +8.05% since 04/22/25 | +7.49% since 04/22/25 | ||
| Low | 424.48 on 04/24/25 | 69.84 on 04/23/25 | 66.80 on 04/23/25 | ||
| High | 441.87 on 04/24/25 | 76.60 on 04/28/25 | 72.60 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +5.07% since 03/28/25 | +7.57% since 03/28/25 | +5.26% since 03/28/25 | ||
| Low | 356.14 on 04/09/25 | 65.94 on 04/09/25 | 57.52 on 04/04/25 | ||
| High | 441.87 on 04/24/25 | 76.60 on 04/28/25 | 73.50 on 04/10/25 | ||
| 3-Month | |||||
| %Chg | +4.35% since 01/29/25 | +7.24% since 01/29/25 | -17.51% since 01/29/25 | ||
| Low | 356.14 on 04/09/25 | 65.94 on 04/09/25 | 57.52 on 04/04/25 | ||
| High | 474.67 on 02/03/25 | 76.73 on 02/14/25 | 93.25 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | -2.43% since 10/29/24 | +9.96% since 10/29/24 | -1.30% since 10/29/24 | ||
| Low | 356.14 on 04/09/25 | 64.89 on 11/12/24 | 57.52 on 04/04/25 | ||
| High | 474.67 on 02/03/25 | 76.73 on 02/14/25 | 93.25 on 02/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,411,612 | 44,842,340 | 27,957,230 | ||
| Shares Outstanding, K | 81,039 | 587,865 | 392,107 | ||
| Annual Sales | 3,897,500,000 | 5,439,500,000 | 4,033,000,000 | ||
| Annual Net Income | 887,870,000 | 4,174,600,000 | 576,200,000 | ||
| Last Quarter Sales | 954,290,000 | 1,412,700,000 | 1,113,500,000 | ||
| Last Quarter Net Income | 216,150,000 | 358,000,000 | 151,700,000 | ||
| 60-Month Beta | 1.50 | 1.15 | 1.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.62 on 02/03/25 | 0.64 on 04/23/25 | 0.45 on 02/13/25 | ||
| Latest Earnings Date | 05/01/25 | 04/23/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.67 | 29.05 | 43.14 | ||